Purifying and cloning interleukin-1 established the role of cytokines as primary mediators of human inflammation. This breakthrough redirected the study of inflammatory diseases, providing a biological framework to explain how immune responses drive pathology. Through rigorous laboratory investigation and clinical research, Charles A. Dinarello transformed the understanding of molecular signals that govern the body's response to injury and infection.
Academic Foundation and Early Career
Born in Boston in 1943, Charles A. Dinarello pursued his medical training at Yale University, where he received his Doctor of Medicine in 1969. His career evolved across several major institutions, including positions at Tufts University, the University of Denver, and the University of Colorado Denver. In his capacity as a physician, university teacher, and cell biologist, he focused his professional inquiries on the mechanisms of the immune system.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Contributions to Cytokine Biology
The research conducted by Dinarello identified cytokines as critical drivers in disease progression. By successfully isolating and cloning interleukin-1, he provided evidence for the validation of these proteins in human health. This work facilitated new clinical strategies, specifically the use of therapies designed to block interleukin-1 to manage chronic inflammatory conditions. His dual appointments included Professor of Medicine at the University of Colorado and Professor of Experimental Medicine at Radboud University Medical Center in Nijmegen.
Global Recognition and Professional Honors
Dinarello has received numerous international accolades for his research contributions. His early recognition includes the 1993 Ernst Jung Prize for Medicine. In 2009, he was awarded the Crafoord Prize in Polyarthritis alongside Tadamitsu Kishimoto and Toshio Hirano, and the Albany Medical Center Prize alongside Ralph M. Steinman and Bruce A. Beutler. Subsequent honors include the 2010 Paul Ehrlich and Ludwig Darmstaedter Prize, the 2010 Novartis Prize for Clinical Immunology, and the 2020 Tang Prize in Biopharmaceutical Science. He is a member of the National Academy of Sciences and a foreign member of the Royal Netherlands Academy of Arts and Sciences.
Fast facts
- Born: 1943, Boston
- Field: Immunology and Cytokine Biology
- Alma Mater: Yale University
- Academic Degree: Doctor of Medicine (1969)
- Significant Contribution: Purified and cloned Interleukin-1
- Awards: Crafoord Prize (2009), Albany Medical Center Prize (2009)
- Current Primary Institution: University of Colorado Denver
- Languages: English, Italian, German
Questions readers ask
What is Charles A. Dinarello best known for?
He is recognized for purifying and cloning interleukin-1, which validated the role of cytokines as mediators of inflammatory diseases.
Where has he held academic positions?
He has held positions at Yale University, Tufts University, the University of Denver, the University of Colorado Denver, and Radboud University Medical Center.
Achievements
- Paul Ehrlich and Ludwig Darmstaedter Prize — 2010
- Albany Medical Center Prize — 2009
- Ernst Jung Prize for Medicine — 1993
- Novartis Prize for Clinical Immunology — 2010
- Crafoord Prize — 2009
- Held posts at University of Colorado Denver, Tufts University and University of Denver
- Fields: medicine, immunology and cytokine
